Heart Failure 2026: Optimising Outcomes Across the Care Pathway (Virtual)

WEBINAR

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: MS Teams

Event Agenda

Learning Outcomes

• How to spot heart failure earlier in busy primary care consultations — and avoid the diagnostic delays that still affect one in three patients.
• When and how to use NT-proBNP, how to interpret borderline results, and how to navigate rapid-access referral pathways with confidence.
• The practical differences between HFrEF, HFmrEF and HFpEF — and why phenotype should shape your management plan.
• How to confidently initiate and titrate the four pillars of guideline-directed medical therapy: ARNI/ACEi/ARBs, beta-blockers, MRAs and SGLT2 inhibitors.
• How to manage common barriers to optimisation — side effects, renal function, blood pressure, and polypharmacy in frail or multimorbid patients.
• The latest evidence on HFpEF and what it means for day-to-day prescribing decisions.
• How to recognise red flags for decompensation and know exactly when to escalate, admit, or refer for advanced therapies.
• How to build a structured annual heart failure review into your practice — including medicines optimisation, lifestyle support and self-management.
• How to work more effectively across the multidisciplinary team: primary care, community heart failure nurses, pharmacy and secondary care.
• Real-world insights from Professor Fuat's own practice, through anonymised case studies and a live Q&A.

Who should attend

This webinar is designed for UK primary care and community healthcare professionals involved in the diagnosis, treatment and long-term management of heart failure, including:

• GPs and GP Registrars
• Practice Nurses and Advanced Nurse Practitioners
• Community and Specialist Heart Failure Nurses
• Primary Care Pharmacists and PCN Clinical Pharmacists
• Community Pharmacists with a clinical role
• Paramedics and Physician Associates working in primary care
• Practice Managers and clinical leads shaping long-term condition pathways

Whether you're newly qualified and building confidence with heart failure management, or an experienced clinician wanting a practical refresh on the latest guideline-directed therapy, this session will give you clear, usable takeaways for your next clinic.

Meet the Speaker

Professor Ahmet Fuat

PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP Cardiology

Honorary Professor, Durham University · GP & GPSI Cardiology (25+ years) · National Programme Director, CliniLink

A Darlington GP for 40 years and one of the UK’s leading voices in primary care cardiology. Professor Fuat established the UK’s first one-stop integrated heart failure clinic in 2002, earned his PhD researching heart failure diagnosis and natriuretic peptides, and has shaped NICE and ESC guidelines on CVD and heart failure — with his HF work featured in the BHF Blueprint for Heart Failure.

Fellow of the RCGP, RCP London, RCP Edinburgh, the ESC and the PCCS, he sits on the editorial boards of the British Journal of Cardiology and the Primary Care Cardiovascular Journal. He teaches because translating evidence into everyday practice is where patient care is won.

 

Symposium Sponsor

Boehringer Ingelheim, provided financial support towards this independent programme.
Boehringer Ingelheim have had no editorial input into or control over the agenda, content development, or choice of speakers, nor any opportunity to influence, except for a non-promotional symposium that Boehringer Ingelheim has created, developed and funded.

Event Sponsors

This meeting has been organised by CliniLink Ltd and is supported by pharmaceutical companies through sponsorship. The sponsors Boehringer Ingelheim were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting. Further information about the event and sponsorship can be found below